5 Healthcare Stocks in Focus; JNJ, PFE, MRK, PG, ABT

Johnson & Johnson ( NYSE: JNJ ) is a New Brunswick, New Jersey-based healthcare company, engaged in the research and development, manufacturing, and sales of a variety of products. The company operates in there segments; Consumer, Pharmaceutical and Medical Devices. Johnson & Johnson through its newly formed indirect wholly-owned subsidiary is making a recommended cash offer for all of the issued and outstanding common shares of Crucell N.V. Johnson & Johnson shares have a 52-week range of $56.86-$66.20. Year-to-date, the stock is down 2.28%, underperforming the broad market. Pfizer Inc. ( NYSE: PFE ) is a New York City-based global pharmaceutical company. The company focuses on applying science and its global resources to improve health and well-being at every stage of life. Pfizer Board of Directors, earlier this week, named Ian C. Read as the company's new CEO after Jeffrey B. Kindler, the current CEO, retired from the company. Read is currently the head of the company's global biopharmaceutical operations. Pfizer shares have a 52-week range of $14-$20.36. Year-to-date, the stock is down 7.92%, underperforming the broad market. Merck & Co. Inc. ( NYSE: MRK ) is a Whitehouse, New Jersey-based global health care company. The company focuses on delivering health solutions through its medicines, vaccines, biologic therapies, and consumer and animal products. Merck announced last week that it entered into a definitive agreement to acquire SmartCells, which is developing a glucose responsive insulin formulation for the treatment of diabetes mellitus. Merck shares have a 52-week range of $30.70-$41.56. Year-to-date, the stock is down 3.48%, underperforming the broad market. The Procter & Gamble Company ( NYSE: PG ) is a Cincinnati, Ohio-based consumer goods company. The company sells its products in over 180 countries. Procter & Gamble reported its first-quarter financial results in October. The company reported first-quarter diluted net earnings per share of $1.02, up 5% over the same period in the previous year. Shares of Procter & Gamble have a 52-week range of $39.37-$65. Year-to-date, the stock is up 3.5%. Abbott Laboratories ( NYSE: ABT ) is an Abbott Park, Illinois-based company, engaged in the discovery, development, manufacturing and sales of diversified line of healthcare products. Abbott shares have a 52-week range of $44.59-$56.79. Year-to-date, the stock is down 13.19%. Disclosure: This corporate profile is provided for information purposes only and should not be used as the basis for any investment decision. We are neither licensed nor qualified to provide investment advice. We were not paid, nor do I hold a position in these stocks. We reserve the right to buy or sell JNJ, PFE, MRK, PG and ABT at any time after this post.
tdp2664Penny Stock Live